Simvastatin treatment in inclusion body myositis (IBM)

Registry ID

EUCTR2007-004359-12

Source registry

EUCTR

Status

Completed

Phase

PHASE3

Sponsor

ISTITUTO NEUROLOGICO "CARLO BESTA"

Start date

2007-04-05

Last update

2026-08-16

Conditions

• INCLUSION BODY MYOSITIS

Summary

Evaluation of safety and tolerability of simvastatin, administered orally to patients with IBM

Locations

• , , Italy

Related clinical trials

• A PHASE II/III RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTER STUDY TO DETERMINE THE EFFICACY AND SAFETY OF ABC008 IN THE TREATMENT OF SUBJECTS WITH INCLUSION BODY MYOSITIS

View on source registry